Magistroni, R. (2017). Tolvaptan: Clinical Evidence for Slowing the Progression of Autosomal Dominant Polycystic Kidney Disease. Giornale Di Clinica Nefrologica E Dialisi, 29(2), 80–84. https://doi.org/10.33393/gcnd.2017.660